CATALYST PHARMACEUTICALS INC shareholders Q3 2023

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Virtus Investment Advisers, Inc. 6,713$78,4750.05%
TWINBEECH CAPITAL LP 213,460$2,495,3470.05%
CIM INVESTMENT MANAGEMENT INC 10,888$127,2810.05%
Engineers Gate Manager LP 102,731$1,200,9250.04%
XML Financial, LLC 30,000$350,7000.04%
AIGEN INVESTMENT MANAGEMENT, LP 17,780$207,8480.04%
SHERBROOKE PARK ADVISERS LLC 10,544$123,2590.04%
Rafferty Asset Management, LLC 510,435$5,966,9850.04%
LSV ASSET MANAGEMENT 1,240,769$14,5050.03%
BOOTHBAY FUND MANAGEMENT, LLC 108,326$1,266,3310.03%
Gotham Asset Management, LLC 114,006$1,332,7300.03%
Hudson Bay Capital Management LP 600,000$7,014,0000.03%
Vestcor Inc 59,615$6970.03%
Renaissance Technologies 1,289,100$15,0700.03%
XTX Topco Ltd 13,227$154,6240.03%
BTC Capital Management, Inc. 18,639$217,8880.02%
Man Group plc 679,577$7,944,2550.02%
State of Wyoming 9,616$112,4110.02%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 400,159$4,677,8590.02%
E Fund Management Co., Ltd. 26,220$3070.02%
External links

This page lists CATALYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view CATALYST PHARMACEUTICALS INC's shareholder history, click here.